Cargando…
The Pathology of EMT in Mouse Mammary Tumorigenesis
Epithelial-mesenchymal-transition (EMT) tumorigenesis in the mouse was first described over 100 years ago using various terms such as carcinosarcoma and without any comprehension of the underlying mechanisms. Such tumors have been considered artifacts of transplantation and of tissue culture. Recent...
Autor principal: | Cardiff, Robert Darrell |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886116/ https://www.ncbi.nlm.nih.gov/pubmed/20521088 http://dx.doi.org/10.1007/s10911-010-9184-y |
Ejemplares similares
-
Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001) -
VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem-like epithelial cells
por: Thrasyvoulou, Soteroula, et al.
Publicado: (2020) -
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan
por: Gibby, Krissa, et al.
Publicado: (2012) -
Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis
por: Liu, Xiong, et al.
Publicado: (2023) -
Separation of clonogenic tumour cells from EMT6 mouse mammary tumours.
por: Twentyman, P. R., et al.
Publicado: (1977)